Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Suzanne D. Conzen

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Conzen, Suzanne

Item TypeName
Concept Cell Line, Tumor
Academic Article Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Academic Article Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells.
Academic Article Ubiquitin-proteasome degradation of serum- and glucocorticoid-regulated kinase-1 (SGK-1) is mediated by the chaperone-dependent E3 ligase CHIP.
Academic Article Hsp90 regulates the phosphorylation and activity of serum- and glucocorticoid-regulated kinase-1.
Academic Article Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer.
Academic Article The MAP kinase phosphatase-1 MKP-1/DUSP1 is a regulator of human liver response to transplantation.
Academic Article Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.
Academic Article Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.
Academic Article Serum- and glucocorticoid-induced protein kinase 1 (SGK1) is regulated by store-operated Ca2+ entry and mediates cytoprotection against necrotic cell death.
Academic Article Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma.
Academic Article Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer.
Academic Article GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome.
Academic Article Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth.
Academic Article Metabolism of megestrol acetate in vitro and the role of oxidative metabolites.
Academic Article Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer.
Academic Article Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association.

Search Criteria
  • Cell Line Tumor